Zinc finger protein 689 (ZNF689)

Zinc finger protein 689 (ZNF689) is a C2H2-type zinc finger transcription factor, classified within the largest family of DNA-binding proteins in the human genome. It is predominantly involved in transcriptional regulation, including promotion of cell proliferation, migration, and survival, particularly in hepatocellular carcinoma (HCC). ZNF689 acts as an oncogene in HCC, where its overexpression is associated with poor prognosis, larger tumor size, and invasive disease. Functionally, ZNF689 suppresses apoptosis by downregulating pro-apoptotic factors and promotes epithelial-mesenchymal transition (EMT) through the Wnt/β-catenin/SNAIL1 signaling pathway. Although no direct therapeutic agents target ZNF689 currently, it represents a potential molecular target for anti-cancer strategies and serves as a biomarker for aggressive disease in liver cancer. Broader safety concerns arise from the transcriptional regulatory role of the protein family, where systemic knockdown could have unpredictable consequences for gene expression[1][2].

Other names

Zinc finger protein 689ZNF689Transcriptional regulator SEHBPFLJ90415TIPUH1Short ORF-encoded histone-binding proteinZNF689 upstream open reading frame proteinTranscription-involved protein upregulated in HCC 1

Transcriptional repression or knockdown (e.g., siRNA targeting ZNF689 to reduce its oncogenic activity and restore apoptosis/proliferative control in HCC models). Inhibition of Wnt/β-catenin pathway (by suppressing ZNF689, EMT and related malignant behaviors are reduced in vitro).